Berberis composition for cognitive health
US-2024424045-A1 · Dec 26, 2024 · US
Sucrose isomerases as food and nutritional supplements
US2025177500A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2025177500-A1 |
| Application number | US-202519038830-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jan 28, 2025 |
| Priority date | Aug 22, 2018 |
| Publication date | Jun 5, 2025 |
| Grant date | — |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Sucrose isomerase is used as a nutritional supplement, or can be mixed in with a powderous food/beverage formulation. When an animal, including a human, consumes sucrose, the sucrose isomerase will act on the sucrose present in the food, and will convert the sucrose to other sugars. This results in lowering of the glycemic index of the food without changing the formulation of the food.
First claim
Opening claim text (preview).
1 . A method of lowering the increase of blood glucose levels in an animal, including a human ingesting sucrose, comprising administering a nutraceutical, pharmaceutical or nutritional supplement comprising a sucrose isomerase to the animal including a human in need thereof. 2 . The method according to claim 1 , wherein the nutraceutical, pharmaceutical or nutritional supplement is suitable for administration to humans. 3 . The method according to claim 1 , wherein the nutraceutical, pharmaceutical or nutritional supplement is suitable for administration to animals. 4 . The method according to claim 1 , wherein the sucrose isomerase comprises an amino acid sequence having at least 90% identity to any one of the sequences of SEQ ID NO: 1-6. 5 . The method according to claim 4 , wherein the sucrose isomerase comprises an amino acid sequence having at least 90% identity to any one of the sequences of SEQ ID NO: 4. 6 . A method of lowering the glycemic index of a food or feed which is consumed by a human or companion animal comprising administering to the human or companion animal a nutraceutical, pharmaceutical or nutritional supplement comprising a sucrose isomerase. 7 . The method according to claim 6 , wherein the nutraceutical, pharmaceutical or nutritional supplement is suitable for administration to humans. 8 . The method according to claim 6 , wherein the nutraceutical, pharmaceutical or nutritional supplement is suitable for companion administration to animals. 9 . The method according to claim 6 , wherein the sucrose isomerase comprises an amino acid sequence having at least 90% identity to any one of the sequences of SEQ ID NO: 1-6. 10 . The method according to claim 9 , wherein the sucrose isomerase comprises an amino acid sequence having at least 90% identity to any one of the sequences of SEQ ID NO: 4. 11 . A method of losing weight or maintaining weight loss in a human or companion animal comprising administering to the human or companion animal a nutraceutical, pharmaceutical or nutritional supplement comprising a sucrose isomerase. 12 . The method according to claim 11 , wherein the nutraceutical, pharmaceutical or nutritional supplement is suitable for administration to humans. 13 . The method according to claim 11 , wherein the nutraceutical, pharmaceutical or nutritional supplement is suitable for administration to companion animals. 14 . The method according to claim 11 , wherein the sucrose isomerase comprises an amino acid sequence having at least 90% identity to any one of the sequences of SEQ ID NO: 1-6. 15 . The method according to claim 14 , wherein the sucrose isomerase comprises an amino acid sequence having at least 90% identity to any one of the sequences of SEQ ID NO: 4.
Assignees
Inventors
Classifications
Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title
Adding ingredients (adding preservatives A23B70/10) · CPC title
Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula · CPC title
- A23L33/10Primary
using additives (addition of substantially indigestible substances A23L33/21) · CPC title
Enzymes · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US2025177500A1 cover?
- Sucrose isomerase is used as a nutritional supplement, or can be mixed in with a powderous food/beverage formulation. When an animal, including a human, consumes sucrose, the sucrose isomerase will act on the sucrose present in the food, and will convert the sucrose to other sugars. This results in lowering of the glycemic index of the food without changing the formulation of the food.
- Who is the assignee on this patent?
- Dsm Ip Assets Bv
- What technology area does this patent fall under?
- Primary CPC classification A23L33/10. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Thu Jun 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).